Impulse Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.00 Cr
- Satisfied Charges ₹ 25.71 Cr
- Revenue Growth -5.90%
- Profit Growth 12.70%
- Ebitda 8.47%
- Net Worth 18.23%
- Total Assets 46.90%
About Impulse Pharma
Impulse Pharma Private Limited (IPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 October 2002 and has a history of 22 years and three months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹20.00 Cr. The company has closed loans amounting to ₹25.71 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Patil, Swapnil Patil, Digambar Zawar, and Three other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2002PTC137705
- Company No.
137705
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Impulse Pharma Private Limited offer?
Impulse Pharma Private Limited offers a wide range of products and services, including Paracetamol Tablets, Combiflam Tablet, Pain Reliever Gel, Combiflam Gel, Pain Relief Spray, Combiflam Pain Relief Spray.
Who are the key members and board of directors at Impulse Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Zawar  | Managing Director | 28-Apr-2016 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Patil | Director | 23-Mar-2010 | Current |
| Swapnil Patil | Director | 23-Mar-2010 | Current |
| Digambar Zawar | Director | 28-Oct-2002 | Current |
| Pushkar Zawar | Director | 28-Mar-2023 | Current |
| Niraj Zawar | Director | 22-Feb-2023 | Current |
Financial Performance of Impulse Pharma.
Impulse Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.9% decrease. The company also saw a substantial improvement in profitability, with a 12.7% increase in profit. The company's net worth Soared by an impressive increase of 18.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Impulse Pharma?
In 2023, Impulse Pharma had a promoter holding of 87.40% and a public holding of 12.60%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kamla Lifesciences LimitedDigambar Zawar and Rajendra Zawar are mutual person
Kamla Films LlpDigambar Zawar is a mutual person
- Triokam Healthcare Llp
Digambar Zawar is a mutual person
- Kamford Healthcare Private Limited
Digambar Zawar and Rajendra Zawar are mutual person
- Conta Healthcare Private Limited
Digambar Zawar is a mutual person
- Kitemed Healthcare Private Limited
Digambar Zawar and Rajendra Zawar are mutual person
Charges (Loans)
₹20.00 Cr
₹25.71 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 20.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2021 | Hdfc Bank Limited | ₹20.00 Cr | Open |
| 12 Sep 2017 | Axis Bank Limited | ₹5.00 Cr | Satisfied |
| 20 Mar 2013 | Others | ₹11.95 Cr | Satisfied |
| 21 Dec 2006 | Bank Of Maharashtra | ₹3.00 Cr | Satisfied |
| 19 Dec 2006 | Bank Of Maharashtra | ₹2.88 Cr | Satisfied |
How Many Employees Work at Impulse Pharma?
Impulse Pharma has a workforce of 100 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Impulse Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Impulse Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
